Search company, investor...

Celerus Diagnostics

Founded Year



Series C - II | Alive

Total Raised


Last Raised

$10M | 11 yrs ago

About Celerus Diagnostics

Celerus Diagnostics is aiming to enhance the diagnostic capabilities of the pathology laboratory. Celerus' Rapid IHC technology aims to provide the capability to decentralize testing, and move results closer to the patient for real time decision making.

Headquarters Location

1005 Mark Ave

Carpinteria, California, 93013,

United States


Missing: Celerus Diagnostics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Celerus Diagnostics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Celerus Diagnostics Patents

Celerus Diagnostics has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Staining, Outlines of countries, Microscopy, Staining dyes, Electromechanical engineering


Application Date


Grant Date



Related Topics

Staining, Outlines of countries, Microscopy, Staining dyes, Electromechanical engineering



Celerus Diagnostics Frequently Asked Questions (FAQ)

  • When was Celerus Diagnostics founded?

    Celerus Diagnostics was founded in 2004.

  • Where is Celerus Diagnostics's headquarters?

    Celerus Diagnostics's headquarters is located at 1005 Mark Ave, Carpinteria.

  • What is Celerus Diagnostics's latest funding round?

    Celerus Diagnostics's latest funding round is Series C - II.

  • How much did Celerus Diagnostics raise?

    Celerus Diagnostics raised a total of $15M.

  • Who are the investors of Celerus Diagnostics?

    Investors of Celerus Diagnostics include Persistence Partners and Hamilton BioVentures.

  • Who are Celerus Diagnostics's competitors?

    Competitors of Celerus Diagnostics include Affidea, Armune Bioscience, Magellan Biosciences, Crescendo Bioscience, Alverix and 13 more.

Compare Celerus Diagnostics to Competitors

Mediracer Logo

Mediracer Specialises In Medical Technology. The company's Core Business Is The Development, Manufacture And Global Sale Of Point Of Care (poc) Diagnostic Testing Equipment For Diseases Of The Peripheral Nervous System.


Sentinel Diagnostics is an Italian company with a long and well established background in the development and production of diagnostic kits destined for use in medical analysis laboratories, hospitals, clinics and private health care structures.


Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.

hanse chemie GmbH

Micronics, Inc. is a developer of near patient in vitro diagnostic products for disease diagnosis, prognosis and treatment monitoring. The Company employs a core patent estate in microfluidics -- the ability to miniaturize complex tests onto credit card size disposable devices. Per the company, tests that today take hours to days in a central laboratory environment are processed on a Micronics disposable device in seconds to minutes.


SPOC is a provider of a diagnostic medical device that identifies the specific myofacial (muscle) trigger points that SPOC says are often overlooked by conventional diagnosis which can cause neck and back pain. This device together with the patented clinical methodology developed by Dr. Norman Marcus, SPOC's chief medical officer and engaged in pain management, aim to provide a complete diagnostic package for accurate and precise identification of muscle pain.

CardioMag Imaging

CardioMag Imaging (CMI) is a medical device company that is engaged in the development and commercialization of a kind of cardiac diagnostic device known as MagnetoCardioGraphs (MCG). The device the company has developed consists of the integration of highly sophisticated sensors, electronics, and software. The company's MCG system is a non-invasive cardiac medical diagnostic device that aims to provide clinically relevant information about heart function without use of ionizing radiation. CardioMag's MCG system is a MCG system to obtain FDA approval.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.